The global chronic wound care market size is expected to reach USD 19.5 billion by 2033, registering a CAGR of 4.11% from 2025 to 2033, according to a new report by Grand View Research, Inc. Diabetes may increase the overall frequency and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, including surgical & traumatic wounds. For instance, according to a research article published in March 2021 by ScienceDirect, the prevalence of diabetes is expected to increase to 120 million people in 2030, thereby propelling market growth.
The outbreak of COVID-19 has created large-scale opportunities for local manufacturers. Due to the restrictions on movement at international borders, the supply chain of major players has been disrupted. This has created an opportunity for local players to enter the market and meet the unmet demands of the end-users. The rising number of cases has led to a shortage of medical supplies; thus, local players are manufacturing products on a larger scale to meet the growing need. Moreover, to enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share.
Technological advancements are projected to have a significant impact on the advanced wound care industry in the coming years. The quality of life of patients suffering from chronic wounds improves as technology advances and becomes more affordable. Traditional wound care and closure products are gradually being replaced by advanced wound care & closure products due to their efficacy and effectiveness in wound management by allowing quicker healing.
Request a free sample copy or view the report summary: Chronic Wound Care Market Report
The advanced wound dressings segment dominated the chronic wound care market in 2024. Advanced wound dressings are specialized medical coverings designed for complex and non-healing wounds, providing moisture management, infection control, and enhanced healing environments
The diabetic foot ulcers segment is dominated chronic wound care market in 2024, due to their high prevalence, severe complications, and rising diabetes burden.
The hospitals segment dominated the chronic wound care market in 2024, Hospitals remain the largest and most influential end-use setting in the chronic wound care market because they manage the highest volume of complex diabetic foot ulcers, pressure injuries, venous ulcers, and post-surgical wounds.
North America held the largest revenue share of 45.47% in 2024 in chronic wound care market, due to the high clinical and economic burden documented by U.S. federal agencies.
Grand View Research has segmented the global chronic wound care market on the basis of on product, application, end use, and region:
Chronic Wound Care Product Outlook (Revenue, USD Million, 2021 - 2033)
Advanced Wound Dressing
Foam Dressing
Hydrocolloid Dressing
Film Dressing
Alginate Dressing
Hydrogel Dressing
Collagen Dressing
Other Dressing
Surgical Wound Care
Suture & Staples
Tissue Adhesive & Sealants
Anti-infective Dressing
Traditional Wound Care
Medical Tapes
Cleansing Agents
Others
Wound Therapy Devices
Negative Pressure Wound Therapy
Oxygen and Hyperbaric Oxygen Equipment
Electric Stimulation Devices
Pressure Relief Devices
Others
Chronic Wound Care Application Outlook (Revenue, USD Million, 2021 - 2033)
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Chronic Wound Care End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Specialty Clinics
Home Healthcare
Others
Chronic Wound Care Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Chronic Wound Care Market
JOHNSON & JOHNSON
BAXTER INTERNATIONAL
Coloplast Corp.
3M
Medline Industries, Inc.
ConvaTec Group PLC
Derma Sciences (Integra LifeSciences)
Cardinal Health
Mölnlycke Health Care AB
Paul Hartmann AG
Smith & Nephew PLC
"The quality of research they have done for us has been excellent..."